N-MYC impairs innate immune signaling in high-grade serous ovarian carcinoma.
Miranda A, Pattnaik S, Hamilton PT, Fuss MA, Kalaria S, Laumont CM, Smazynski J, Mesa M, Banville A, Jiang X, Jenkins R, Cañadas I, Nelson BH.
Miranda A, et al. Among authors: pattnaik s.
Sci Adv. 2024 May 17;10(20):eadj5428. doi: 10.1126/sciadv.adj5428. Epub 2024 May 15.
Sci Adv. 2024.
PMID: 38748789
Free article.